ASAP Act
Congress Proposes Medicare Coverage for New Blood Tests to Detect Early Alzheimer's
Stalled
No legislative action in over 90 days.
Legislative Progress
Key Points
- This bill would require Medicare to pay for new types of blood tests that can find signs of Alzheimer’s disease and other forms of dementia. These tests are designed to catch the disease early, even before a person starts showing clear symptoms.
- To be covered, the tests must be approved by the FDA. While the focus is on blood tests that look at genes and proteins, the government could also choose to cover similar tests that use urine samples or medical imaging.
- The goal is to help doctors find brain diseases sooner so patients can start treatments or make plans earlier. Currently, many dementia tests can be expensive or hard to get, and this change would make them more available to seniors.
- If passed, Medicare would start paying for these screenings on January 1, 2028. This gives the government and health care providers time to set up the rules for how the tests will be used and paid for.
Impact Analysis
Personal Impact
Programs
This bill would add blood-based dementia screening tests to the list of services Medicare covers, meaning seniors wouldn't have to pay the full cost out of pocket. Early detection of Alzheimer's and related dementias could help millions of Medicare beneficiaries get diagnosed sooner, allowing them to start treatment earlier and plan for the future. This is especially significant as roughly 6 million Americans currently live with Alzheimer's, most of whom are on Medicare.
Disabilities
Milestones
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
5 articlesIt’s time for bold action on neurodegenerative diseases
The article advocates for the bipartisan Alzheimer's Screening and Prevention (ASAP) Act, noting it would create a pathway for Medicare to cover FDA-approved blood-based tests for early dementia detection, empowering personal choice and responsibility in brain health.
Vern Buchanan Pushes 'ASAP Act' Expanding Alzheimer's Screening
Florida Congressman Vern Buchanan and Rep. Paul Tonko introduced the ASAP Act to ensure seniors have timely access to innovative diagnostic tests. The bill aims to modernize Medicare's process for covering FDA-approved blood-based tests for early Alzheimer's detection.
ASAP Act Would Expand Alzheimer's Detection
The Alzheimer's Screening and Prevention Act (ASAP) reflects growing recognition that early detection is essential. The bill would empower the HHS Secretary to give Medicare beneficiaries access to FDA-cleared biomarker tests, removing current legislative barriers to preventive services.
Source Information
Document Type
Congressional Bill
Official Title
ASAP Act
Data Sources
Sponsor
Cosponsors
(38)Analysis generated by AI. Always verify with official sources.